Waystar Considers Sale Amidst Software Sector Challenges
Healthcare software firm Waystar, facing a 24% stock price drop, explores sale options.
Healthcare software company Waystar is reportedly exploring strategic options, including a potential sale, according to sources familiar with the matter. This move comes as the company's market value has plummeted to approximately $4.8 billion following a 24% decline in its stock price this year amid a broader downturn in the software sector.
Waystar's Strategic Positioning
Waystar, headquartered in Lehi, Utah, and Louisville, Kentucky, was formed in 2017 through the merger of healthcare revenue management firms Zirmed and Navicure. The company has positioned itself as a technology provider that automates and manages administrative tasks in healthcare, seeking to capitalize on the higher valuations typically associated with tech firms. Despite initial investor enthusiasm, which saw shares peak at $45 in 2025, concerns over potential disruptions from artificial intelligence have pressured the stock.
Engagement with Evercore
In pursuit of its strategic exploration, Waystar has engaged investment bank Evercore to advise on the process. Although the discussions are in early stages, the possibility of a sale could test the market's current appetite for software businesses. However, sources caution that plans are not final, and a sale might not occur.
Ownership and Market Impact
Waystar's ownership includes major stakeholders such as EQT, the Canada Pension Plan Investment Board (CPPIB), and Bain Capital, who took the company public in 2024. EQT holds a 13% stake, making it the largest shareholder, while CPPIB and BlackRock Institutional Trust Company own 10% and 8%, respectively. The company's declining market performance reflects broader investor concerns in the software sector, exacerbated by fears of technological advancements potentially overshadowing existing software solutions.
Waystar declined to comment on the potential sale, and Evercore has not responded to requests for comment. Similarly, EQT, CPPIB, and BlackRock have withheld public statements regarding the matter.